nodes	percent_of_prediction	percent_of_DWPC	metapath
Clodronate—SLC25A6—brainstem—meningioma	0.0772	0.151	CbGeAlD
Clodronate—SLC25A5—Host Interactions of HIV factors—AP1B1—meningioma	0.0693	0.141	CbGpPWpGaD
Clodronate—SLC25A6—Host Interactions of HIV factors—AP1B1—meningioma	0.058	0.118	CbGpPWpGaD
Clodronate—SLC25A6—spinal cord—meningioma	0.048	0.0941	CbGeAlD
Clodronate—SLC25A5—medulla oblongata—meningioma	0.0468	0.0918	CbGeAlD
Clodronate—SLC25A4—Host Interactions of HIV factors—AP1B1—meningioma	0.0453	0.0924	CbGpPWpGaD
Clodronate—SLC25A5—HIV Infection—AP1B1—meningioma	0.045	0.0918	CbGpPWpGaD
Clodronate—SLC25A4—medulla oblongata—meningioma	0.0439	0.0861	CbGeAlD
Clodronate—SLC25A5—spinal cord—meningioma	0.0417	0.0819	CbGeAlD
Clodronate—SLC25A4—spinal cord—meningioma	0.0391	0.0767	CbGeAlD
Clodronate—SLC25A6—cerebellum—meningioma	0.038	0.0746	CbGeAlD
Clodronate—SLC25A6—HIV Infection—AP1B1—meningioma	0.0377	0.0769	CbGpPWpGaD
Clodronate—SLC25A5—cerebellum—meningioma	0.0331	0.0649	CbGeAlD
Clodronate—SLC25A4—cerebellum—meningioma	0.031	0.0608	CbGeAlD
Clodronate—SLC25A6—brain—meningioma	0.0309	0.0606	CbGeAlD
Clodronate—SLC25A4—HIV Infection—AP1B1—meningioma	0.0294	0.0601	CbGpPWpGaD
Clodronate—SLC25A5—brain—meningioma	0.0269	0.0527	CbGeAlD
Clodronate—SLC25A4—brain—meningioma	0.0252	0.0494	CbGeAlD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—HES1—meningioma	0.0134	0.0273	CbGpPWpGaD
Clodronate—PTGS2—S1P1 pathway—PDGFB—meningioma	0.0122	0.0248	CbGpPWpGaD
Clodronate—SLC25A5—Disease—AP1B1—meningioma	0.011	0.0225	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—TSHB—meningioma	0.00943	0.0192	CbGpPWpGaD
Clodronate—SLC25A6—Disease—AP1B1—meningioma	0.00924	0.0188	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—ALAD—meningioma	0.009	0.0184	CbGpPWpGaD
Clodronate—PTGS2—medulla oblongata—meningioma	0.00881	0.0173	CbGeAlD
Clodronate—PTGS2—C-MYB transcription factor network—CD34—meningioma	0.00837	0.0171	CbGpPWpGaD
Clodronate—PTGS2—spinal cord—meningioma	0.00786	0.0154	CbGeAlD
Clodronate—SLC25A6—Metabolism—ALAD—meningioma	0.00754	0.0154	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—TSHB—meningioma	0.00736	0.015	CbGpPWpGaD
Clodronate—SLC25A4—Disease—AP1B1—meningioma	0.00721	0.0147	CbGpPWpGaD
Clodronate—SLC25A5—Disease—CST3—meningioma	0.00656	0.0134	CbGpPWpGaD
Clodronate—PTGS2—cerebellum—meningioma	0.00623	0.0122	CbGeAlD
Clodronate—SLC25A6—Metabolism of proteins—PLAUR—meningioma	0.00622	0.0127	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ALAD—meningioma	0.00589	0.012	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—TSHB—meningioma	0.0058	0.0118	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CST3—meningioma	0.0055	0.0112	CbGpPWpGaD
Clodronate—PTGS2—brain—meningioma	0.00506	0.00993	CbGeAlD
Clodronate—SLC25A6—Metabolism—TSHB—meningioma	0.00486	0.00991	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—PLAUR—meningioma	0.00485	0.0099	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—HES1—meningioma	0.00434	0.00885	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CST3—meningioma	0.00429	0.00875	CbGpPWpGaD
Clodronate—SLC25A5—Disease—HES1—meningioma	0.00386	0.00787	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—meningioma	0.00382	0.00779	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—TSHB—meningioma	0.00379	0.00774	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—meningioma	0.00343	0.007	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PDGFB—meningioma	0.0033	0.00673	CbGpPWpGaD
Clodronate—SLC25A6—Disease—HES1—meningioma	0.00323	0.0066	CbGpPWpGaD
Clodronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—meningioma	0.00291	0.00595	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PDGFB—meningioma	0.00277	0.00564	CbGpPWpGaD
Clodronate—SLC25A4—Disease—HES1—meningioma	0.00252	0.00515	CbGpPWpGaD
Clodronate—SLC25A5—Disease—ERBB2—meningioma	0.00221	0.00451	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PDGFB—meningioma	0.00216	0.0044	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PTEN—meningioma	0.00189	0.00385	CbGpPWpGaD
Clodronate—SLC25A6—Disease—ERBB2—meningioma	0.00185	0.00378	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PTEN—meningioma	0.00158	0.00322	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PTEN—meningioma	0.00158	0.00322	CbGpPWpGaD
Clodronate—SLC25A4—Disease—ERBB2—meningioma	0.00145	0.00295	CbGpPWpGaD
Clodronate—PTGS2—Disease—AP1B1—meningioma	0.00143	0.00291	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PTEN—meningioma	0.00132	0.0027	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.00129	0.00263	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PTEN—meningioma	0.00123	0.00252	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALAD—meningioma	0.00116	0.00237	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TP53—meningioma	0.0011	0.00225	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.0011	0.00224	CbGpPWpGaD
Clodronate—SLC25A5—Disease—AKT1—meningioma	0.00109	0.00222	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PTEN—meningioma	0.00103	0.00211	CbGpPWpGaD
Clodronate—SLC25A6—Disease—AKT1—meningioma	0.000911	0.00186	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—AKT1—meningioma	0.000911	0.00186	CbGpPWpGaD
Clodronate—PTGS2—Disease—CST3—meningioma	0.000848	0.00173	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—AKT1—meningioma	0.000763	0.00156	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—TSHB—meningioma	0.00075	0.00153	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.00075	0.00153	CbGpPWpGaD
Clodronate—SLC25A4—Disease—AKT1—meningioma	0.000711	0.00145	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.000633	0.00129	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—AKT1—meningioma	0.000596	0.00122	CbGpPWpGaD
Clodronate—PTGS2—Disease—HES1—meningioma	0.000499	0.00102	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000459	0.000936	CbGpPWpGaD
Clodronate—PTGS2—Disease—PDGFB—meningioma	0.000427	0.000871	CbGpPWpGaD
Clodronate—PTGS2—Disease—ERBB2—meningioma	0.000286	0.000584	CbGpPWpGaD
Clodronate—PTGS2—Disease—PTEN—meningioma	0.000244	0.000498	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PTEN—meningioma	0.000204	0.000417	CbGpPWpGaD
Clodronate—PTGS2—Disease—AKT1—meningioma	0.000141	0.000287	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—AKT1—meningioma	0.000118	0.00024	CbGpPWpGaD
